High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study

Journal of Health Economics and Outcomes Research
Julie KanterJincy Paulose

Abstract

The transition from pediatric to adult care in the US is often difficult for individuals with sickle cell disease (SCD). Young adults (18 to 25 years of age) have higher acute care utilization and an increased risk of poor outcomes. The current study was designed to provide greater insights into patients (16 to 18 years of age) with SCD prior to their transition to adult care. To describe current treatment patterns, pain crises prevalence, SCD-related complications, and healthcare resource utilization (HCRU) in 16-to-18-year-old patients with SCD. From 1/1/2015-6/30/2017 using MarketScan Databases, patients were included if they were 16 to 18 years old at the index date, had ≥1 inpatient or 2 outpatient SCD diagnosis claims during the identification period, and were continuously enrolled in the database for at least one year prior (baseline) and post index date. Outcomes included medications, disease management interventions, Charlson Comorbidity Index (CCI), vaso-occlusive (VOC) crises requiring healthcare visits, HCRU, and SCD complications. 1,186 patients were included; most (64.3%) were female. The mean CCI was 1.3 (SD: 0.7). In the overall cohort, patients experienced an average of 3.9 (SD: 4.2) VOCs and most patients (61....Continue Reading

References

Mar 1, 1992·The Journal of Pediatrics·B BalkaranG R Serjeant
Oct 6, 1997·Journal of the American Academy of Dermatology·B E SerjeantG R Serjeant
Feb 7, 2004·Blood·Charles T QuinnGeorge R Buchanan
Nov 30, 2005·American Journal of Hematology·Sadhna M ShankarMarie R Griffin
Dec 13, 2006·British Journal of Haematology·Lori A StylesFrans A Kuypers
Feb 12, 2009·Hemoglobin·Nicola ConranFernando F Costa
Oct 13, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·George BuchananShalini Shenoy
Mar 3, 2010·Blood·Charles T QuinnGeorge R Buchanan
Apr 2, 2010·American Journal of Preventive Medicine·Kathryn L Hassell
Apr 8, 2010·JAMA : the Journal of the American Medical Association·David C BrousseauClaudia A Steiner
May 11, 2010·Survey of Ophthalmology·Mohammed ElagouzSobha Sivaprasad
Dec 7, 2010·Lancet·David C ReesMark T Gladwin
May 18, 2011·Pediatric Blood & Cancer·Jean L RaphaelThomas Giordano
Sep 8, 2011·American Journal of Hematology·Susanna Bortolusso AliMarvin Reid
Oct 3, 2012·Pediatrics·Michael R DeBaun, Joseph Telfair
Nov 16, 2012·Pediatric Blood & Cancer·Timothy L McCavitCharles T Quinn
Apr 24, 2013·The Journal of Urology·Emilie K Johnson, Caleb P Nelson
Nov 19, 2013·Pediatric Clinics of North America·Charles T Quinn
Sep 10, 2014·JAMA : the Journal of the American Medical Association·Barbara P YawnJoylene John-Sowah
Apr 26, 2015·The Journal of Emergency Medicine·Morey A BlinderFrancis Vekeman
Apr 20, 2017·The New England Journal of Medicine·Frédéric B PielDavid C Rees
Nov 23, 2017·MMWR. Morbidity and Mortality Weekly Report·Mary HulihanPhoebe Thorpe

❮ Previous
Next ❯

Software Mentioned

SAS
MarketScan

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.